Podcasts about jynneos

This episode reviews five oral abstracts which addressed the 2023 clade I mpox outbreak and recent or ongoing research on the efficacy of tecovirimat, the JYNNEOS vaccine, and alternative therapies. IDWeek 2024 occurred in October 2024. View episode transcript at www.std.uw.edu.This podcast is dedicated to an STD [sexually transmitted disease] review for health care professionals who are interested in remaining up-to-date on the diagnosis, management, and prevention of STDs. Editor and host Dr. Meena Ramchandani is an Assistant Professor of Medicine at the University of Washington (UW) and Program Director of the UW Infectious Diseases Fellowship Program. 

In his weekly clinical update, Dr. Griffin informs us about mpox circulation and new vaccine approval, the Marburg virus outbreak in Rwanda, and the largest outbreak of whooping cough in a decade before reviewing the recent statistics on SARS-CoV-2 infection, the WasterwaterScan dashboard, immunity among those over 65th following the 3rd dose of the COVID-19 mRNA vaccine, where to find PEMGARDA, a reminder of how and when to use steroids to treat COVID-19, how well the SARS-CoV-2 rapid antigen test performed, what do when healthcare workers succumb to SARS-CoV-2 infection, the effect of remdesivir on survival and readmission of hospitalized patients, if cognitive impairment following virus infection impairs one's driving and how long COVID affects Chinese society. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Undiagnosed MPXV infections are high in men who have sex with men (BMC Infectious Diseases) WHO, now a vaccine approval agency, Jynneos for teens  (CIDRAP) Mpox outbreak global trends (WHO) How to stop Marburg virus (Rwanda Biomedical Centre) Marburg virus fact sheet (Rwanda Biomedical Centre) Largest whooping cough outbreak in US in a decade (NPR) COVID-19 deaths (CDC) COVID-19 national and regional trends (CDC) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Insurance relates to effectiveness and waning of immunity following 3rd dose of mRNA COVID-19 vaccine? (JID) New preventive COVID-19 agent (ISDA) IDSA Guidelines on the Treatment and Management of Patients with COVID-19 (IDSA) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) How well do you test: performance of the SARS-CoV-2 antigen rapid detection test (eBioMedicine) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Infectious Disease Society guidelines for treatment and management (ID Society) Drug interaction checker (University of Liverpool) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC) Managing healthcare staffing shortages (CDC) Steroids, dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Remdesivir-associated survival outcomes among immunocompromised patients (CID) Remdesivir Effectiveness in Reducing the Risk of 30-day Readmission in Vulnerable Patients (CID) Measurement of circulating viral antigens post-SARS-CoV-2 infection (CMI: Clinical Microbiology and Infection) DUCI: driving under cognitive influence of COVID-19 (Neurology) Long COVID facts and findings: (LANCET: Regional Health Western Pacific) Letters read on TWiV 1158 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Sanofi has signed a $326 million deal with Orano Med for radiopharma, following a similar deal made in September. Sage Therapeutics is laying off 33% of employees to support the launch of its postpartum depression drug. Bristol-Myers Squibb's Opdivo showed a progression-free survival advantage over Pfizer's Adcetris in a late-stage study for Hodgkin's lymphoma. Kezar Life Sciences has cut its lupus program after patient deaths and is now focusing on autoimmune hepatitis. The Institute for Clinical Research is researching ways to extend healthy lifespan. Other news includes GSK and Viiv touting the effectiveness of a long-acting HIV prep, Bavarian Nordic's Jynneos eliciting a robust antibody response in adolescents, and AbbVie winning approval for an advanced Parkinson's treatment. Takeda has walked away from a partnership for Huntington's disease after investing $260 million.

Nidhi Bouri, DAA at USAID Bureau for Global Health, joined us to speak to the U.S. response to the dangerous mpox outbreak (clade 1b) centered in the Democratic Republic of Congo, boosted by President Biden's commitment at UNGA to $500m in support, including 1 million vaccine doses. Much better data is urgently needed on the needs for diagnostics and vaccines. Tensions remain high among Africa CDC, WHO, and other key institutions with proven response capability, most notably Gavi, UNICEF and the Global Fund. Much is not known about modes of transmission, and the durability and efficacy of the Jynneos vaccine for clade 1b. As the virus inevitably lands in the United States, communications will be critical. Some important progress was seen in the High Level Meeting on anti-microbial resistance. The Marburg outbreak in Rwanda is of acute concern for multiple reasons: no vaccine, little testing, little knowledge of the pattern of spread. It is crunch time, as multiple replenishments converge. “Let's be clear, there is not enough money.”

In his weekly clinical update, Dr. Griffin deep dives into the durability of the antibody response following mpox vaccination, vaccine security, global mpox circulation, the origins of SARS-CoV-2, including a list TWiV episodes and combatting scientific misinformation, before reviewing the recent statistics on SARS-CoV-2 infection, the WasterwaterScan dashboard, where to find PEMGARDA, a reminder of how and when to use steroids to treat COVID-19, what do when healthcare workers succumb to SARS-CoV-2 infection, if remdesivir + dexamethasone lowers mortality of hospitalized COVID-19 patients and the finding of how SARS-CoV-2 infection impacts memory and cognition. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Waning vaccine protection against mpox…..isn't this the way the humoral immune response works? (CIDRAP) Uncontrollable mpox outbreak in Africa  (Reuters) Antibodies elicited by the Jynneos vaccine against mpox contract after 6-9 months….can you believe? (medrxiv) Mpox vaccine for adolescents approved (Pharmaceutical Technology) Clade 1b mpox visiting India (CIDRAP) Mpox clade 1b in Kerala (ANI South Asia's Leading Multimedia News Agency) US government orders $63M worth of small pox/mpox vaccine (Reuters) Mpox donations boosting global supply (US Department of Health and Human Services) I million mpox vaccine doses for Africa….with love from US government (CIDRAP) Speed doses of mpox vaccine (CIDRAP) Mpox vaccine donations (UNICEF) Bavarian Nordic mpox vaccine (Yahoo finances) Early epicenter of COVID-19 pandemic Huanan seafood market (Science) Wildlife trade likely source of SARS-CoV-2 (Science) Zoonotic origins of SARS-CoV-2 (Science) Surveillance at the Huanan Seafood market (Europe PMC) TWiV shout outs…..all for the SARS-CoV-2 spill over from nature TWiV 1019: Eddie Holmes on SARS-CoV-2 origins TWiV 1017: From Nature, not a lab TWiV 995: Viral origin stories TWiV 940: Eddie Holmes in on viral origins TWiV 876: Spillover market with Michael Worobey TWiV 762: SARS-CoV-2 origins with Robert Garry TWiV 760: SARS-CoV-2 origins with Peter Daszak, Thea Kølsen Fischer, Marion Koopmans TWiV 774: Kristian Andersen, Robert Garry, and the deleted SARS-CoV-2 sequences Genetic tracking of market wildlife and viruses at Huanan Market (Cell) Combatting scientific misinformation (microbeTV: TWiV) COVID-19 deaths (CDC) COVID-19 national and regional trends (CDC) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Suggestion for the use of a new preventive COVID-19 agent (IDSA) IDSA Guidelines on the Treatment and Management of Patients with COVID-19 (IDSA) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Infectious Disease Society guidelines for treatment and management (ID Society) Drug interaction checker (University of Liverpool) Molnupiravir outcomes 3 and 6 months after treatment (LANCET Infectious Diseases) Antivirals and post-COVID-19 conditions (LANCET Infectious Disease) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC) Managing healthcare staffing shortages (CDC) Steroids,dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Lower mortality risk associated with remdesivir + dexamethasone versus dexamethasone for hospitalized COVID-19 patients (CID) Changes in memory and cognition during the SARS-CoV-2 human challenge study (eClinical Medicine) Letters read on TWiV 1152 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

En éste video revisamos la actual emergencia internacional del virus MPox también conocido como viruela del mono o viruela símica y qué significa la declaración de emergencia sanitaria internacional.Consulta más información aquí:Declaración de la emergencia: https://www.paho.org/es/noticias/14-8-2024-director-general-oms-declara-emergencia-salud-publica-importancia-internacionalVacunas: https://cdn.www.gob.pe/uploads/document/file/3749143/NT_40_monkeypox_vacuna_JYNNEOS.pdfCheca el video aquí: https://www.youtube.com/watch?v=FzOKI57xc38&t=18sÚnete al canal para acceder a increibles beneficios:https://www.youtube.com/channel/UC4_NOlVIu_FjdTGhok5t4lg/joinAgenda una consulta médica al WhatsApp +52 55 4482 1519Visita nuestra tienda en donde encontrarás nuestros cursos y material educativo:http://bit.ly/3TivzpfSupport the show

Antonio Martínez Dagnino se mantiene como director del SAT   Lluvias ayudan a controlar incendios en Bolivia  Más detalles en nuestro Podcast

Lluvias fuertes en 22 estados, en el Edomex y CDMX Autoriza Cofepris registro sanitario a la vacuna Jynneos vs viruela símica  Cancelan festejos por Fiestas Patrias en Cotija, Michoacán  Más detalles en nuestro Podcast

Why is bird flu such a big deal? What happens if a human gets the bird flu? What is monkeypox? Is there a new COVID booster? Where can I get a COVID vaccine? Our guest is the American Medical Association's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH. AMA CXO Todd Unger hosts.

In this episode, we discuss the newest pandemic and those profiting from the vaccines, the election illusion, and much more. Rumble: https://rumble.com/c/TheFactHunter Website: thefacthunter.com Email: thefacthunter@mail.com Snail Mail: George Hobbs PO Box 109 Goldsboro, MD  21636Show Notes:Gold https://www.nasdaq.com/articles/sky-high-gold-prices-are-sending-a-warning-about-war.-pay-attention. HHS United States Government's Response to the Clade I Mpox Outbreak https://www.hhs.gov/about/news/2024/08/14/united-states-governments-response-clade-i-mpox-outbreak-democratic-republic-congo-other-countries-region.html Bavarian Nordic scores $157M contract to replenish US supplies of smallpox/mpox vaccine Jynneos https://www.fiercepharma.com/pharma/bavarian-nordic-scores-1568m-contract-replenish-us-supplies-combination-smallpoxmpox-vaccine#:~:text=Following%20the%20commercial%20launch%20of,agreement%20with%20the%20U.S.%20government. https://jynneos.com In an Oligarchy, Voting is a Tool to Manufacture the Illusion of Consent https://www.activistpost.com/2016/10/oligarchy-voting-tool-manufacture-illusion-consent.html Who Owns America? Oligarchs Hav

What are the symptoms of Mpox? Who is high risk for monkeypox? Is raw milk illegal? When is Hajj 2024? Are there long term effects of meningococcal disease? Our guest is AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH. American Medical Association CXO Todd Unger hosts.

First prescription smartphone app approved for major depressive disorder; Novel blood test to detect TBI; Zevtera approved for bloodstream infections; Mpox vaccine is now commercially available; Algorithm cleared for LVEF dectection.  

Dr. Lisa Law and Dr. Randy Taplitz share the latest evidence-based recommendations from ASCO on vaccines in adults with cancer. They discuss recommended routine preventative vaccinations, additional vaccinations and revaccinations for adults undergoing HSCT, CD19 CAR-T treatment, or B cell-depleting therapy, guidance for adults with cancer traveling outside the U.S., and recommendations for vaccination of household and close contacts of adults with cancer. Dr. Law and Dr. Taplitz also share their insights on the guideline, including the importance of this guideline for adults with cancer and their clinicians, future advances in research, and current unmet needs. Read the full guideline, “Vaccination of Adults with Cancer: ASCO Guideline” at www.asco.org/supportive-care-guidelines. TRANSCRIPT This guideline, clinical tools, and resources are available at http://www.asco.org/supportive-care-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology, https://ascopubs.org/doi/10.1200/JCO.24.00032       The ASCO Specialty Societies Advancing Adult Immunization (SSAAI) Project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award to the Council of Medical Specialty Societies (CMSS) (with 100 percent funded by CDC/HHS). The contents are those of the authors and do not necessarily represent the official views of nor endorsement, by CDC/HHS or the U.S. Government. Brittany Harvey: Hello, and welcome to the ASCO Guidelines Podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one, at asco.org/podcasts.  My name is Brittany Harvey, and today, I am interviewing Dr. Lisa Law from Kaiser Permanente and Dr. Randy Taplitz from City of Hope Comprehensive Cancer Center, authors on “Vaccination of Adults with Cancer: ASCO Guideline.” Thank you for being here, Dr. Law and Dr. Taplitz. Dr. Lisa Law: Thank you. Dr. Taplitz: Thank you, Brittany. Brittany Harvey: Before we discuss this guideline, I'd like to take note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO conflict of interest policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Taplitz and Dr. Law, who have joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes.  So then, to dive into the content, here first, Dr. Taplitz, can you provide a general overview of both the scope and purpose of this guideline on vaccination of adults with cancer? Dr. Randy Taplitz: Yes, so people with cancer often experience a compromised immune system due to a variety of factors. This includes chronic inflammation, impaired or decreased function of the hematopoietic system, and treatments that compromise their immune function. Because of this, people with cancer are at a higher risk for infection, including with vaccine-preventable diseases. Also, response to vaccines in patients with cancer may well be affected by this underlying immune status, and their anticancer therapy, as well as the severity of the underlying malignancy. The purpose of vaccination in this group of patients is to prevent infection or to attenuate the severity of the disease when infection cannot be fully prevented.   This ASCO review builds on a 2013 guideline by the Infectious Diseases Society of America, or IDSA, and uses what's called a systematic literature review of 102 publications between 2013 and 2023. This includes 24 systematic reviews, 14 randomized clinical trials, and 64 non-randomized studies. The largest body of evidence in these studies, not surprisingly, addresses COVID vaccines on the efficacy and safety of vaccines used by adults with cancer or their household contacts. ASCO convened an expert panel to review this evidence and formulate recommendations for vaccinations in this population. Brittany Harvey: Understood. I appreciate that context, Dr. Taplitz. So then, next, Dr. Law, I'd like to review the key recommendations of this guideline. The guideline addresses four overarching clinical questions. So starting with the first question, what are the recommended routine preventative vaccinations for adults with cancer? Dr. Lisa Law: Thank you, Brittany. Before I start, I just want to wholeheartedly thank the first author of this paper, Dr. Mini Kamboj, Dr. Elise Kohn from the NCI, as well as the ASCO staff in putting this publication and guideline together. It is a very, very important guideline, and I echo everything Dr. Taplitz just said.  So going back to your question, what are the recommended routine preventative vaccines for adults with cancer? As per this guideline, there are about 7 to 8 based on patient age and risk. Namely, they are: seasonal flu, RSV for those aged 60 or above, COVID-19, Tdap, Hepatitis B, Shingrix, Pneumococcal vaccine, and the HPV vaccine. These vaccines should ideally be given two to four weeks before therapy. However, non-live vaccines can be given anytime during or after chemo, immunotherapy, hormonal treatment, radiation, or surgery. Brittany Harvey: Excellent. Thank you for reviewing those vaccinations and the timing of them as well. So then, following those recommendations, Dr. Taplitz, what additional vaccinations and revaccinations are recommended for adults undergoing hematopoietic stem cell transplantation, CD19 CAR-T treatment, or B-cell depleting therapy?  Dr. Randy Taplitz: Many studies have shown that stem cell transplant recipients essentially lose immunity from childhood immunizations, and we know that these individuals are very vulnerable to infection, particularly in the first year after transplant. Revaccination is critical to help restore their immunity. The optimal timing of vaccination is based on our understanding of adequate immune reconstitution with B and T-cell recovery so that the individual can mount a response to the vaccine. We know that a lot of factors influence this immune reconstitution, including the age of the stem cell transplant recipient, the source of the donor, the time from transplant, graft-versus-host disease prophylaxis, the treatment and severity of graft-versus-host disease, and the vaccine type and antigens used.   There are a number of bodies throughout the world, IDSA as I mentioned, CDC, American Society for Transplant and Cellular Therapy, European Society for Blood and Marrow Transplant, and European Conference for Infections and Leukemia. All of these bodies have guidelines that approach vaccination in stem cell transplants. However, variation does exist in the use of a variety of things including whether to use immune predictors to help guide vaccination, and there is really not consensus on whether this immune predictor guided vaccination is more likely to produce a protective immune response versus a standardized schedule. In addition, the duration of protection is incompletely understood.  The bottom line in these guidelines is that they recommend complete revaccination starting for most vaccines at 6 to 12 months after stem cell transplant, in order to restore vaccine-induced immunity. And I just want to go through a few of the particulars. For COVID-19, which is a three-dose series in the primary series, influenza - generally high-dose influenza - and pneumococcal vaccine, PCV20 in general, ultimately four doses, can be administered, starting as early as three months after transplant. Although there is really not much data to guide the use of the recombinant zoster vaccine in allogeneic stem cell transplant, the vaccine can be administered after the end of antiviral prophylaxis, which in general is 12 to 18 months after allogeneic and 3 to 12 months after autologous stem cell transplant. Some of the other vaccines, such as hepatitis B, Tdap, meningococcal vaccines, and HPV revaccination in those less than 45 are also recommended.   I want to also spend the moment talking about the two recently licensed RSV vaccines, which were essentially studied in less compromised hosts and really without any immunogenicity data in stem cell transplant, and thus, there is no recommendation in this guideline for the use of these vaccines after transplant. Live vaccines, such as MMR and varicella – varicella would be in varicella-seronegative patients without a prior history of varicella – should be delayed for at least two years and only given in the absence of active graft-versus-host disease or immunosuppression.  Moving briefly to CAR T, which is an immunotherapy that involves adoptive cell therapy, given the available data and after a review by the group, it was recommended that adults with hematopoietic malignancies receiving CAR T therapy directed against B-cell antigens should receive influenza and COVID-19 vaccines either two weeks before lymphodepletion or no sooner than three months after the completion of therapy. Administration of non-live vaccines preferably should occur before CAR T treatment or at least 6 to 12 months after, following the same timing as what we recommend for stem cell transplant. There is really little data to guide the safety and timing of administration of live vaccines after CAR T therapy.   In terms of adults receiving B-cell depleting therapy, they are generally unable for time to mount an effective humoral response but may have at least partially intact cellular immune responses. They are encouraged to be revaccinated for COVID-19 no sooner than six months after completion of B-cell depleting therapy, and they should receive influenza vaccine approximately four weeks from the most recent treatment dose for patients on chronic therapy. For other non-seasonal immunizations, vaccines ideally should be given two to four weeks before commencing anti-CD20 therapy or delayed until 6 to 12 months after completion, except for the recombinant zoster vaccine, which can be given one month after the most recent dose of B-cell depleting therapy. Brittany Harvey: I appreciate you reviewing each of those vaccinations and when they should be given, and reviewing the available data – albeit, limited data – in these situations.  So beyond these routine preventative vaccinations and revaccinations that you've both just described, Dr. Law, what additional vaccinations does the expert panel recommend for adults with cancer traveling outside the United States? Dr. Lisa Law: Good question. As per these ASCO guidelines, adults with solid or blood cancer traveling outside of the United States should follow the CDC standard recommendations for their destination. For the 2024 CDC Yellow Book, travel vaccines, in general, should be delayed until three months from the last chemotherapy or, and for those with solid tumors, ideally when the disease is in remission. Of note, hepatitis A, typhoid, inactivated polio, Hep B, rabies, meningococcal vaccine, and Japanese encephalitis vaccines are considered to be safe. In all cases of travel, patients should be counseled by their healthcare provider about the travel timing, with the additional attention to the regional seasonality of infections, for instance, influenza is more common in late summer in Australia, and also with attention to any outbreaks that may be occurring globally at the time of travel. Brittany Harvey: Absolutely. Those are key points for clinicians to discuss with their patients as they consider upcoming travel.  So then, the final clinical question that the panel addressed, Dr. Taplitz, what vaccinations does the panel recommend for household and close contacts of adults with cancer?  Dr. Randy Taplitz: Thank you. Yes, it is recommended that all household members and close contacts, when possible, be up to date on their vaccinations. And the only further thing I would say is that there are some special considerations for the use of live vaccines in household contacts, particularly in stem cell transplant recipients. Contacts of people who receive stem cell transplants should preferably receive inactivated influenza vaccines. As was mentioned, MMR and varicella vaccines are both safe to administer to close contacts. Vaccine strain transmission to immunocompromised hosts has not been associated with MMR use in family members.   Eleven cases of the varicella vaccine strain transmission are described in the published literature, but none occurred in compromised hosts. Because the vaccine strain can cause severe and fatal varicella in profoundly immunocompromised people, precautions are advised to avoid close contact with a person with a vaccine-induced rash. For household contact travelers, MMR and yellow fever vaccines are considered safe. Oral cholera should be avoided. For smallpox vaccines, the second-generation ACAM2000 has rarely been associated with vaccinia transmission and should be avoided because of this. But the live replication-deficient MVA-based JYNNEOS vaccine is felt to be safe for household contacts of immunocompromised individuals. Brittany Harvey: I appreciate you reviewing the importance of vaccination for household and close contacts, and some of those precautions that individuals should take. I appreciate you both for reviewing all of these recommendations.  So then in your view, Dr. Law, what is the importance of this guideline, and how will it impact both clinicians and adults with cancer? Dr. Lisa Law: In my opinion, this is a very important guideline that is long overdue in the oncology community and will have a huge impact on both clinicians and adults with cancer. Over the years, I have often been asked by my colleagues and patients, “Can I have the flu vaccine, and if so, when?” So this guideline really is going to be helpful. More importantly, our cancer patients are living much longer. They may have years of quality of life even with third or fourth line of treatment, especially, for instance, like CAR T for myeloma and lymphoma. However, we know that with additional treatment, that carries a substantial risk of infection complication among these immunocompromised patients. So it is of paramount importance to inform our patients and colleagues to be proactive in advocating preventive therapy ahead of time, meaning trying to get the patients appropriately vaccinated as early as possible to generate immunity.  Another case in point is the Shingrix vaccine. I used to see lots of shingles, but ever since we have the recombinant Shingrix, I have fewer encounters. And this is huge because post-herpetic neuralgia robs a patient's quality of life. So, again, it is very important to recommend appropriate vaccines for our cancer patients.  Brittany Harvey: Absolutely. It is key to ensure patients receive these preventative vaccines, and we hope that this guideline puts an emphasis on that for clinicians and patients.  So finally, to wrap us up, Dr. Taplitz, what are the current gaps in knowledge regarding the vaccination of people with cancer? Dr. Randy Taplitz: There are a number of really important gaps in knowledge and really critical unmet needs that require research and other dedicated efforts. Among these are, and I think paramount, are really the participation of people with cancer with varied types of immunocompromise in vaccine trials. Where vaccine trials are only for cancer patients, obviously is ideal, testing vaccines in the appropriate population. But when that's not feasible, pre-existing cancer should not preclude eligibility, and inclusion of cohorts of people receiving anticancer treatment should be incorporated prospectively. So that's really critical because the quality of our guidelines is based upon the data. We use the data for developing guidelines and gathering more data in the particular patient population is really, really critical.  Secondly, work for creating more immunogenic vaccines and research to understand the immune response to vaccines after immuno-depleting therapies, particularly with newer therapies such as CAR T and newer B cell therapies, bispecific antibodies, etc. is really critical. We need to really understand the immune response and have the most potent vaccines available to these people who may have impaired immune responses.  Switching gears a little bit, we really need mechanisms to promote institutional commitment to integrate and sustain immunization best practices for people with cancer. This will largely be through multidisciplinary, team-based approaches, protocol-based vaccination standing orders, and leveraging data sharing so that we can all be on the same page with giving vaccines to these individuals. We also need education and evidence-based decision-making tools, emphasizing preventive care through immunization, the availability of educational resources to clinicians and patients to address commonly asked questions and also misconceptions about vaccination, that's absolutely critical.  And finally, I think we need to develop strategies for addressing unique challenges and factors contributing to vaccine hesitancy during cancer therapy. We need to focus on patient and clinician communication, and very importantly, we need to consider health equity considerations in the development and approach to vaccines in these compromised patients. Brittany Harvey: Definitely, we'll look forward to research and advances in these areas that you've just described to support these guidelines and increase vaccine uptake.  So I want to thank you both so much for your work on this important guideline, and thank you for your time today, Dr. Law and Dr. Taplitz. Dr. Lisa Law: Thank you.  Brittany Harvey: And thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/supportive-care-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, available in the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast, and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.   Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.      

This episode discusses four MMWR reports. First, despite very low risk of getting malaria in the U.S., locally acquired malaria cases reported in Florida and Texas highlight importance of quick diagnosis, treatment, and malaria prevention methods. Second, more than 33 million children in Africa are missing a measles vaccine, highlighting the urgent need to increase immunization efforts to prevent outbreaks and deaths. Third, the JYNNEOS vaccine offers protection against hospitalization among people with mpox, including people with HIV. Finally, norovirus was the main cause of illness among more than two dozen hikers on Washington's Pacific Crest Trail.

This episode discusses four MMWR reports. First, a norovirus outbreak with more than 300 cases in Illinois is linked to an ill worker who continued working while sick. Second, COVID-19 vaccines protect young children against COVID-19-associated emergency department and urgent care visits. Third, adults older than 50 who received the JYNNEOS vaccine had lower rates of hospitalization with mpox. For the best protection, all eligible adults should receive 2 doses of JYNNEOS vaccine, regardless of childhood smallpox vaccination status. Finally, increased vaccination and prompt virus detection are needed to eradicate polio in Pakistan.

Featuring articles on anticoagulation for stroke and atrial fibrillation, familial clonal hematopoiesis and long telomeres, JYNNEOS vaccine effectiveness against mpox, and mirikizumab for ulcerative colitis; a review article on artificial intelligence in molecular medicine; a case report of a man with a solitary fibrous tumor and hypoglycemia; and Perspective articles on sharing pathogen genomic sequence data; on hydrofluorocarbons, climate, and health; and on patient-assistance programs, kickbacks, and the courts.

This episode discusses four MMWR reports. First, although the number of mpox cases has decreased since the peak of the U.S. outbreak in August 2022, the risk for future outbreaks remains. Clinicians need to be alert for new cases and people at risk should continue to take prevention measures. Second, a new report looking at data from 12 U.S. jurisdictions shows the JYNNEOS vaccine is effective at preventing mpox in people at high risk for mpox. Third, a study of mpox patients in New York provides additional evidence showing the JYNNEOS vaccine is highly effective against mpox. Finally, a new report looks at which occupations had the highest, or lowest, percentages of workers with disability.

Jednym z największych sukcesów ludzkości było wyeliminowanie ospy prawdziwej* - choroby zakaźnej, której straszne epidemie przez długie tysiąclecia aż do lat 70. XX wieku zabiły setki milionów ludzi na całym świecie. Kres temu położyły masowe szczepienia. W 1980 roku Światowa Organizacja Zdrowia (WHO) oficjalnie ogłosiła akt eradykacji, czyli całkowitej eliminacji ospy prawdziwej. To dziś jedyna spośród chorób zakaźnych, której udało się pozbyć z ludzkiej populacji. Jak do tego doszło? Kim były ostatnie ofiary ospy prawdziwej? Kiedy po raz ostatni nawiedziła Polskę? I dlaczego wirusa ospy trzeba bezwzględnie trzymać pod kluczem?W tym odcinku Podcastu Crazy Nauki odwiedzimy starożytną Grecję, Amerykę w czasach konkwistadorów, XVIII-wieczną Anglię, Wrocław z 1963 roku, Indie sprzed 50 lat czy laboratorium mikrobiologiczne w USA w czasach współczesnych. *nie należy jej mylić z ospą wietrzną, chorobą zakaźną dużo mniej groźną od ospy prawdziwej, na którą wciąż choruje wielu ludziZapraszamy do posłuchania naszego podcastu!Jeśli Wam się spodoba, zajrzyjcie do nas na Patronite i rozważcie wsparcie: https://patronite.pl/crazynauka Jeśli wolisz jednorazowo postawić nam kawę, to super. Dzięki!

In this episode, Monica Gandhi, MD, MPH, and Chloe Orkin, MBChB, FRCP, MD, discuss considerations for monkeypox, now called mpox, in people with HIV, including:The history of monkeypox (mpox)The current monkeypox (mpox) outbreakWhat we knew about monkeypox (mpox) in PWH prior to the current outbreakData in PWH from an international case series of monkeypox (mpox)CDC data regarding monkeypox (mpox) in PWHMonkeypox (mpox) treatment recommendationsDrug–drug interaction considerations between tecovirimat for monkeypox (mpox) and ARTMonkeypox (mpox) vaccination recommendations for PWHGlobal access to monkeypox (mpox) treatments and vaccinesWhether monkeypox (mpox) is a sexually transmitted infection and the implications of thatOngoing research on monkeypox (mpox) in PWHMonica Gandhi, MD, MPHProfessor of MedicineDivision of HIV, Infectious Diseases, and Global MedicineUniversity of California, San FranciscoMedical DirectorWard 86 HIV ClinicSan Francisco General Hospital San Francisco, CaliforniaChloe Orkin, MBChB, FRCP, MDProfessor of HIVQueen Mary, University of LondonConsultant PhysicianLead for HIV ResearchBarts Health NHS TrustThe Royal London HospitalLondon, United KingdomLink to full program:https://bit.ly/3HPu4Lk

In his weekly clinical update Dr. Griffin discusses Dr. Griffin discusses progress toward poliomyelitis eradication in Afghanistan, reduced risk for Mpox after receipt of 1 or 2 doses of JYNNEOS vaccine compared with risk among unvaccinated persons, reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters, authorized updated (Bivalent) COVID-19 vaccines for children down to 6 months of age, low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by parental mRNA vaccine or a BA.5-bivalent booster, efficacy of antiviral agents against omicron subvariants BQ.1.1 and XBB, incidence of viral rebound after treatment with Nirmatrelvir-Ritonavir and Molnupiravir, and the effectiveness of coronavirus disease 2019 (COVID-19) vaccine in the prevention of post–COVID-19 conditions. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Progress toward Poliomyelitis eradication in Afghanistan (CDC) Reduced risk for Mpox after receipt of 1 or 2 Doses of JYNNEOS vaccine (CDC) Reduced airborne transmission of BA.1 Omicron virus in Syrian hamsters (PLOS) Authorized bivalent vaccines for children down to 6 months of age (FDA) Low neutralization of BA.2.75.2, BQ.1.1, and XBB.1 by parental mRNA vaccine (Nature) Efficacy of antiviral agents against Omicron subvariants BQ.1.1 and XBB (NEJM) Viral rebound after treatment with Nirmatrelvir-Ritonavir and Molnupiravir (JAMA) Paxlovid patient eligbiliity screening checklist (FDA) Effectiveness of COVID-19 vaccines in prevention of post–infection conditions (ASHE) Contribute to our MicrobeTV fundraiser at PWB Dr. Griffin's treatment guide (pdf) Letters read on TWiV 964 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

What is the relationship between gut microbiome and depressive symptoms?

This week on Pharm5: Bivalent booster for kids Jynneos protects against monkeypox Dexcom G7 approved for diabetes Rezlidhia (olutasidenib) approved for AML PCAT retirement in 2024 Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD References: Coronavirus (COVID-19) update: FDA authorizes updated (bivalent) covid-19 vaccines for children down to 6 months of age. U.S. Food and Drug Administration. https://bit.ly/3UIOuIP. Accessed December 8, 2022. Webinar November 29, 2022 - flu, RSV, COVID-19 and other respiratory threats this fall and Winter. Centers for Disease Control and Prevention. http://bit.ly/3Bf21AX. Published November 16, 2022. Accessed December 8, 2022. Reduced risk for Mpox after receipt of 1 or 2 doses of JYNNEOS vaccine compared with risk among unvaccinated persons - 43 U.S. jurisdictions, July 31–October 1, 2022. Centers for Disease Control and Prevention. https://bit.ly/3FzvTdL. Published December 8, 2022. Accessed December 8, 2022. Dexcom G7 receives FDA clearance: The most accurate continuous glucose monitoring system cleared in the U.S. Business Wire. https://bit.ly/3UMwMnv. Published December 8, 2022. Accessed December 8, 2022. Center for Drug Evaluation and Research. FDA approves Olutasidenib. U.S. Food and Drug Administration. https://bit.ly/3W2vSo5. Accessed December 8, 2022. Pharmcas Community. Retirement of the Pharmacy College Admission Test (PCAT). https://bit.ly/3Y9EomW. Published December 6, 2022. Accessed December 8, 2022.

In his weekly clinical update Dr. Griffin discusses progress toward poliomyelitis eradication in Pakistan, polio by the numbers , influenza and COVID-19 vaccination coverage among health care personnel, phase 1/2a safety and immunogenicity of an adenovirus 26 vector RSV vaccine encoding prefusion F in adults 18–50 years and RSV seropositive children 12–24 months, receipt of first and second doses of JYNNEOS vaccine for prevention of Monkeypox, distinguishing SARS-CoV-2 persistence and reinfection, Novavax NVX-COV2373 triggers potent neutralization of Omicron sub-lineages, association between regular physical activity and the protective effect of vaccination against SARS-CoV-2 in a South African case, COVID-19 outcomes in solid organ transplant recipients who received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab treatment, Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralizing antibodies, and Tocilizumab versus Baricitinib in hospitalized patients with severe COVID-19. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Progress toward Poliomyelitis eradication (CDC) Polio by the numbers (JID) Influenza & COVID-19 vaccination coverage among health care personnel (CDC) Phase 1/2a Safety & Immunogenicity of an adenovirus RSV Vaccine (JID) Receipt of first & second doses of JYNNEOS vaccine  (CDC) Distinguishing SARS-CoV-2 persistence and reinfection (CID) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) Novavax triggers potent neutralization of Omicron sub-lineages (bioRxiV) Association between physical activity & vaccination protective effect (BMJ) PAXLOVID patient eligibility screening checklist (FDA) COVID-19 outcomes in solid organ transplant recipients who received monoclonal antibodies (Transplantation) Omicron BA.2.75.2 exhibits escape from neutralizing antibodies (bioRxiV) Tocilizumab vs. Baricitinib in hospitalized patients with severe COVID-19 (CMI) Dr. Griffin's treatment guide (pdf) Contribute to Floating Doctors fundraiser at PWB Letters read on TWiV 949 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

CDC epidemiologist Dr. Bryce Furness discusses recent national monkeypox trends, the potential impact of waning smallpox immunity, and possible future monkeypox trends with the National STD Curriculum Podcast Editor Dr. Meena Ramchandani. This fourth episode of the ongoing monkeypox series was recorded in September 2022.  View episode transcript and references at www.std.uw.edu.This podcast is dedicated to an STD [sexually transmitted disease] literature review for health care professionals who are interested in remaining up-to-date on the diagnosis, management, and prevention of STDs. Editor and host Dr. Meena Ramchandani is an Assistant Professor of Medicine at the University of Washington (UW) and Medical Director of the Public Health – Seattle & King County Sexual Health Clinic.  

Epidemiologist and cardiologist, Dr. Peter McCullough, explains the serious issues with the JYNNEOS vaccine used for Monkeypox.

This week on Pharm5: ProAir HFA discontinued New MPJE blueprint PREP Act Expansion Ebola outbreak in Uganda American Pharmacists Month Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD References ProAir HFA®. Albuterol Inhalers. https://bit.ly/3CfEpvB. Accessed October 6, 2022. ProAir manufacturer discontinuation. NC Medicaid. https://bit.ly/3Vm54Qn. Accessed October 6, 2022. Home Page: Department of Vermont health access. Home Page | Department of Vermont Health Access. https://bit.ly/3Mayn45. Accessed October 6, 2022. Multistate Pharmacy Jurisprudence Examination (MPJE): NABP. National Association of Boards of Pharmacy. https://bit.ly/3RJpYWz. Published October 6, 2022. Accessed October 6, 2022. HHS amends prep act declaration increasing workforce authorized to administer monkeypox vaccines. https://bit.ly/3MbuX0V. Accessed October 6, 2022. JYNNEOS vaccine fact sheet - EZIZ. https://bit.ly/3V8zvJx. Accessed October 7, 2022. Daniel R. Lucey MD. Uganda ebola outbreak grows to more than 60 cases, 882 contacts and a fourth district. IDSA Home. https://bit.ly/3RXIavL. Accessed October 6, 2022. Ebola virus disease. World Health Organization. https://bit.ly/3T68x3d. Accessed October 6, 2022. American Pharmacists Month. APhM. https://bit.ly/3CEncNK. Accessed October 6, 2022. Pharmacy technician day. ASHP. https://bit.ly/3rCTN0f. Accessed October 6, 2022.

This episode discusses five MMWR reports. The first report provides early evidence of protection from monkeypox after a single dose of the JYNNEOS vaccine. The second report describes the low monkeypox transmission risk among residents of Cook County Jail in Chicago. The third report examines acute respiratory illnesses among children and teens associated with enterovirus D68. The fourth report highlights the Advisory Committee on Immunization Practices' recommendations for the cholera vaccine. And the last report examines the effectiveness of a second COVID-19 booster dose against hospitalization and death among nursing home residents.

Findings about the the monkeypox vaccine, Jynneos, are preliminary, but encouraging.

Canary Cry News Talk #532 - 09.07.2022 - Recorded Live to Tape! DRAGON QUEEN - Robot CEO, Metaverse Muzzle, Truss the Lizard, Cold Art Harvard: Index of MSM Ownership (Harvard.edu) SHOW NOTES HELLO, RUN DOWN METAVERSE Bizarre Muzzle Microphone Keeps Your Mouth in the Metaverse (Gizmodo)   DAY/PERSONAL/EXEC   FLIPPY UPDATE AI-powered humanoid robot is the new CEO of a Chinese metaverse company (WION)   GREAT RESET/QANON QAnon Is Losing It Over the Queen's Death (Vice) TUCKER CARLSON: Queen Elizabeth II being attacked because she lived in a better time (Fox) Clip: Joe Biden response in 33 second video (Sky News) → Prince Charles to launch 'Great Reset' project to rebuild post coronavirus (Telegraph) (Archive)   PARTY TIME BREAK 1: TREASURE 1   LIZ TRUSS Conspiracists name new UK PM Liz Truss in theory about WEF 'Great Reset'. The facts? (abc net) → WEF's “Conspiracy” Rebuttal is Weak Sauce against Facts, Friends of Science Society (PRWeb)   POLYTICKS Clip: MSNBC host says “both sides” dangerous, lazy way of covering politics (Twitter) → Making a martyr: Steve Bannon is paraded through New York court in CUFFS… (DailyMail)    BREAK 2: TREASURE 2   COVID/WACCINE 10.5 million children orphaned or lost primary caregiver due to COVID, study (Yahoo/USA Today)  → Companies are dropping vaccine mandates (Axios)    MONKEYPOX Joe Biden's Monkeypox Czar: Gay Doctor In Drag Who Wants To ‘Dismantle Stigma' (DailyCaller) Sources: [CDC ACAM200 , Vaccinia Virus , Jynneos vaccine trial information, FDA's animal rule]   BREAK 3: TALENT   ANTARCTICA Artist found inspiration at the end of the Earth (SunThisWeek)   BREAK 4: TIME/END END   This Episode was Produced By: Sir MORV Knight of the Burning Chariots**   EXECUTIVE PRODUCERS Maureen M** Rachelle**   Producers Sir Morv Knight of the Burning Chariots, Jason F, Bryan B, Sir LX Protocol V2 Knight of the Berrean Protocol, Sir JC Knight of the Technosquatch, Sir Darrin Knight of the Hungry Panda's, Runksmash, Gail M, Veronica D, Sir Scott Knight of Truth, Sir Casey the Shield Knight   Audio Production Kalub   Visual Art Dame Allie of the Skillet Nation Sir Dove Knight of Rusbeltia Pizza Rat   MICROFICTION Runksmash: Derwin leaps from the back of the robot cow, slides into the nearest tent, and rolls himself up to blend in with the strange tubes inside, then by happenstance he witnesses a diminutive crocodile climb out of a hippie mechsuit; aghast he stares on.    CLIP PRODUCER Emsworth, FaeLivrin, Epsilon   TIMESTAPERS Jackie U, Jade Bouncerson, Christine C, Pocojoyo   SOCIAL MEDIA DOERS Dame MissG of the OV and Deep Rivers   LINKS HELP JAM ADDITIONAL STORIES US Trained Ukrainian Missile Who Sunk Russian Warship, Pentagon Official Says (Defense One)  Russia could be ‘North Korea on steroids' when Putin is replaced, former Kremlin advisor (CNBC) Iran claims that it has new artificial intelligence capabilities (J Post)  Ghost in the machine? Creepy corpse-like woman dubbed 'Loab' haunting the internet (DailyMail) Embryos with DNA from three people develop normally in first safety study (Nature)  ‘Girls Who Code' Team Up With Tomahawk Missile Maker Raytheon (Vice)  Leaked Oath Keepers Data Reveals U.S. States With Most Members (Newsweek)  North Korea has up to 5K tons of cyanide and other chemical weapons: Report (NK News)  North Korea declares itself a nuclear weapons state, in 'irreversible' move (CNN)  Russia says it will retaliate against EU visa restrictions (Reuters) Washington hits back at ‘desperate' Putin after he slammed U.S. ‘dictatorship' (CNBC) Luxury fashion houses are funneling millions into the metaverse. But to what end? (CNN) The Metaverse, Robots, Fictional Influencers: How We Shop Is Evolving (Forbes) Tesla Suit promo video (Tesla Suit) Ford prepares to enter the Metaverse with virtual automobiles and NFTs (Cointelegraph) Articulated Arm Robot Market is Set to Experience Revolutionary Growth (Open PR) Single-port robotic system for prostatectomy ‘has made a huge difference,' surgeon says (Haelio) Johnson & Johnson to develop spine robot to rival medtech competitors (Becker Spine) UW researchers create tool that designs 3D-printed grippers (Robot Report) King Charles III, the new monarch (BBC) U.K. Reveals the Name Former Prince Charles Will Adopt as King (US News) → Clip: Airpot employees dance during Queen passing report (BBC/Twitter) Queen Elizabeth II dies: Jeff Bezos, Bill Gates, other business leaders react (FOX)

Hundreds of thousands of Americans have received the Jynneos monkeypox vaccine since the U.S. outbreak started in May, but there's a long list of things we still don't know about how efficacious it will be. Plus, Professor Robert Blendon, the co-director of the POLITICO-Harvard polls, on the most interesting toplines from survey data released today.

Today we discuss Monkeypox and the new political crisis for the upcoming midterm elections. Many—though not all—of the reported monkeypox cases have been among gay, bisexual, and other men who have sex with men, according to the CDC. Our Socials: Rumble: https://rumble.com/user/JaredRayburnPodcast Tiktok: https://www.tiktok.com/@jaredrayburnpodcast TRUTH: https://truthsocial.com/@JaredRayburnPodcast Facebook: https://www.facebook.com/JaredRayburnPodcast/ YouTube: https://www.youtube.com/channel/UCZcMYeWWcoDrjPxuJlpr-oQ/ Instagram: https://www.instagram.com/activate.studio/ Twitter: https://twitter.com/magentaminute If you would like to reach us or support our ministry please visit: https://jaredrayburn.com Podcast sponsors: Mariah Grumblat https://movingwithmariah.com or call: 248-379-0023 Amer Bally - Bally Team Lending 586-945-3424 03 Fitness & Nutritional Supplements https://www.03Fitnessequipment.com or call: 260-573-7277 Ally's Cleaning Service 269-601-6503 Podcast references: https://www.cdc.gov/poxvirus/monkeypox/about/cdc-response.html https://biblehub.com/hebrew/4284.htm https://www.cdc.gov/poxvirus/monkeypox/vaccines/vaccine-basics.html https://podcasts.apple.com/fi/podcast/monkeypox-who-is-really-at-risk-with-dr-kelly-victory/id635045292?i=1000576572800 **Vaccine information: Monkeypox Vaccines The JYNNEOS vaccine is approved for prevention of smallpox and monkeypox. It is the primary vaccine being used during this outbreak in the U.S. The ACAM2000 vaccine is an alternative to JYNNEOS. It is also approved to help protect against smallpox and monkeypox. --- Send in a voice message: https://podcasters.spotify.com/pod/show/jared-rayburn/message

In this episode of the CBJ Real News Podcast Show - Special Series *10* Minutes of Pure Truth and Fury, John Di Lemme interviews Dr. Betsy Eads on the Killer Monkeypox Shot a.k.a. Jynneos Make sure to share this... Want More *Real News* go to... http://www.ConservativeBusinessJournal.com/updateme John and Christie Di Lemme are Unapologetically Focused on Transforming and Protecting America! Interested in knowing How you can join our Army of '100' Conservative Millionaires we are Creating Nationwide to Transform and Protect America? Simply Call/Text (561) 847 – 3467 or Email John@ConservativeBusinessJournal.com and say “Video” and our team will get you the details Interested in the Healthcare Coverage you heard John and Dr. Betsy talk about... Simply Call/Text (561) 847 – 3467 or Email John@ConservativeBusinessJournal.com and say “Healthcare” and our team will get you the details

In this episode of the Special Series *10* Minutes of Pure Truth and Fury, John Di Lemme interviews Dr. Betsy Eads on the Killer Monkeypox Shot a.k.a. Jynneos Make sure to share this... Want More *Real News* go to... http://www.ConservativeBusinessJournal.com/updateme John and Christie Di Lemme are Unapologetically Focused on Transforming and Protecting America! Interested in knowing How you can join our Army of '100' Conservative Millionaires we are Creating Nationwide to Transform and Protect America? Simply Call/Text (561) 847 – 3467 or Email John@ConservativeBusinessJournal.com and say “Video” and our team will get you the details Interested in the Healthcare Coverage you heard John and Dr. Betsy talk about... Simply Call/Text (561) 847 – 3467 or Email John@ConservativeBusinessJournal.com and say “Healthcare” and our team will get you the details

Do you have questions about monkeypox? Download the season 2 finale of the Public Health Out Loud podcast to get answers. Co-hosts Dr. Jim McDonald and Dr. Philip Chan talk about the origins of monkeypox, how it's spread, and how to protect yourself. They also talk about the JYNNEOS vaccine, and how Rhode Island is administering it. Get the facts about monkeypox from our public health experts so you can recognize misinformation when it's circulating online.  To learn more about Rhode Island's monkeypox vaccination strategy or to sign up for the Vaccine Interest Notification List, visit health.ri.gov/monkeypox. If you're listening outside of Rhode Island, visit your local health department's website for information about vaccination.  Thank you for listening to season 2 of Public Health Out Loud! Subscribe to the podcast and follow the Rhode Island Department of Health on Facebook, Twitter, and Instagram for updates on season 3.  

  Vidcast:  https://youtu.be/QqX4vyzngIk   The shortage of the available Danish monkeypox vaccine Jynneos has driven the CDC to recommend vaccination with one-fifth the originally recommended dose injected between the layers of the skin rather than beneath the skin.  Some scientists are pushing back on the plan claiming that the so-called intradermal vaccination route is not as effective.   The literature pushes back on this notion.  As early as 1980, a Swedish study on the typhoid vaccine showed that the intradermal route generated comparable protective antibody titers when compared with the subcutaneous route.  The added benefits of intradermal vaccinations: 7.5 fold lower incidence of local skin and general febrile reactions as well as a 3.7 fold lower incidence of severe local skin reactions.   More recently, in 2004, Dr. Anthony Fauci himself co-authored a New England Journal article about stretching available doses of flu vaccine using a smaller dose of vaccine administered intradermally rather than intramuscularly.  He points out that intradermal vaccination may actually induce a stronger immune response than intramuscular vaccination when used for not only flu vaccinations but also for those against hepatitis B, rabies, and other infectious disease,   If you need a monkeypox vaccination, get the intradermal jab.  If you can't get the vaccine, protect yourself with hygenic sexual practices, avoiding contact with those demonstrating skin rashes, and us hand and surface cleansing using disinfectants and go ol' 70% isopropyl alcohol.   https://www.cambridge.org/core/services/aop-cambridge-core/content/view/5612191EDC16CF79A2B2C88B6FBA4ABE/S0022172400026462a.pdf/intradermal-versus-subcutaneous-immunization-with-typhoid-vaccine.pdf https://www.nejm.org/doi/full/10.1056/NEJMe048314   #monkeypox #vaccination #intradermal #subcutaneous   

A federal judge in Florida announced Thursday he is "inclined" to release parts of the affidavit that led to the FBI search of Mar-a-Lago earlier this month. That means it could be made public, giving the Justice Department a week to submit its redactions. Meanwhile, Allen Weisselberg, the former chief financial officer of the Trump Organization, pleaded guilty to tax evasion – and agreed to testify in a broader investigation of the company.And in headlines: Israeli forces raided the offices of seven Palestinian rights groups, the U.S. boost its supply of the Jynneos monkeypox vaccine, and a federal judge ordered Starbucks to re-hire seven employees fired for union organizing.Show Notes:National Vulnerability Database: “Rhythm Nation” DoS resonant-frequency attack – https://nvd.nist.gov/vuln/detail/CVE-2022-38392Vote Save America: Fuck Bans Action Plan – https://votesaveamerica.com/roe/Crooked Coffee is officially here. Our first blend, What A Morning, is available in medium and dark roasts. Wake up with your own bag at crooked.com/coffeeFollow us on Instagram – https://www.instagram.com/whataday/For a transcript of this episode, please visit crooked.com/whataday 

Amerika gaan sy voorraad entstof teen aappokke 'n hupstoot gee deur 'n bykomende 1,8 miljoen dosisse van Bavarian Nordic se Jynneos-entstof beskikbaar te stel. In Amerika is meer as 13 500 aappokke-gevalle in 49 deelstate aangemeld, wat meer as 'n derde van die wêreld se 39 000 gevalle verteenwoordig. Die sentrum vir siektebeheer en -voorkoming se direkteur, Rochelle Walensky, sê sowat 98 persent van die gevalle in die land is mans:

The Hawaii Department of Health on Thursday reported two additional cases of monkeypox, bringing the total number of infections in an ongoing outbreak to 18. The additional cases include an Oahu resident whose case is still being investigated and a non-resident who was diagnosed on Oahu and had a recent history of travel outside Hawaii. “While the risk to most Hawaii residents remains low, local transmission of monkeypox is occurring,” said Deputy State Epidemiologist Dr. Nathan Tan, in a statement. “The growing number of cases in Hawaii underscores the importance of vaccination—if you are eligible, please take this step to protect yourself and our community.” The DOH is reminding residents that the JYNNEOS vaccine is available to those who are eligible:See omnystudio.com/listener for privacy information.

Here are the links for everything discussed in Episode 76. Times are also below so feel free to skip around and get to the updates that interest you.  (1:32) FDA issues EUA for JYNNEOS vaccine (5:05) FDA approves Enhertu for NSCLC w/ HER2 expression Other FDA approvals: (8:13) - Myfembree (8:43) - Nubeqa (9:08) - Calquence (9:36) - Xofluza CDC website for COVID information - get boosted!FDA monkeypox response websiteConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

AMA Director of Science, Medicine and Public Health Andrea Garcia, JD, MPH, walks through the updated CDC COVID-19 Guidance, including what's changed, what hasn't, and what it means for kids headed back to school during National Immunization Awareness Month this August. #ivax2Protect Plus, FDA has authorized a plan for using a partial dose of the Jynneos monkeypox vaccine via intradermal injection to extend supply. This also allows use of Jynneos to prevent monkeypox in kids under 18. American Medical Association CXO Todd Unger hosts. Visit AMA's monkeypox resource center here: https://www.ama-assn.org/delivering-care/public-health/monkeypox-resource-center

Michael Merchlinsky joins TWiV to discuss the development of two smallpox antiviral drugs and two smallpox vaccines and their uses during the monkeypox outbreak. Hosts: Vincent Racaniello, Dickson Despommier, Rich Condit, and Kathy Spindler Guest: Michael Merchlinsky Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Michael on Anything but academic (TWiM 145) Development of Tecoviromat (TPOXX) (Antiviral Res) Use of Jynneos vaccine (MMWR) Limitations of Tecoviromat (NEJM) Poliovirus in NYC wastewater (NY Times) Letters read on TWiV 927 Timestamps by Jolene. Thanks! Weekly Picks Dickson – Duke Ellington and his Orchestra. Signature song: Take The A Train; Signature album: Black, Brown, And Beige and Herding Cats: Harlem 1958 Kathy – How the US Postal Service reads terrible handwriting Rich – JWST/chorizo gag Vincent – Bat Conservation Trust Listener Picks Bill – The End of Manual Transmission J – How the Krebs cycle powers life and death – with Nick Lane Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv

Geoffrey Klerekoper joins to debut his NEW SONG “These Little Ones”, inspired by our documentary! Geoffrey also emphasizes the importance of using music to promote the Word of God, and the duty of a Christian presence in the music industry! Dr. Jane joins to discuss the Monkeypox Madness. In 2019, the FDA approved Jynneos as a vaccine for the Monkeypox virus. Now, thanks to the refusal of homosexuals to stop having revolting group sex parties, Monkeypox is spreading all around the world. Mental health in America is steadily declining. Matt Gallant joins us today to show us how Magnesium might be the solution to this growing problem. The Federal government is out of control, and we need America First lawyers and attorneys to put it back in order. Lawyer Joe McBride joins the show to detail his historic lawsuit, suing for millions against the Federal government. Watch this new show NOW at https://StewPeters.com! Visit our friends at Goldco! Call 855-706-GOLD or visit  https://goldco.com/sp Prepare your family for famine and shortages by purchasing food through: https://heavensharvest.com/ Check out https://nootopia.com/StewPeters for help increasing your mental & physical strength to battle the deep-state's KRYPTONITE plot against Americans! Get Dr. Zelenko's Anti-Shedding Treatment, NOW AVAILABLE FOR KIDS: https://zstacklife.com/ CACOA is a super food, and may be the missing link to strength and happiness. Buy it now: https://shop.earthechofoods.com/stew Go Ad-Free, Get Exclusive Content, Become a Premium user: https://redvoicemedia.com/premium Follow Stew on Gab: https://gab.com/RealStewPeters See all of Stew's content at https://StewPeters.com Watch full episodes here: https://redvoicemedia.net/stew-full-shows Check out Stew's store: https://stewmerch.com Support our efforts to keep truth alive: https://www.redvoicemedia.com/support-red-voice-media/

Ya aprobaron la vacuna JYNNEOS, cuida tu salud. --- Send in a voice message: https://anchor.fm/alternativa3/message

This week on Pharm5: Inflation Reduction Act's impact on Medicare Part D Monkeypox and Jynneos vaccine updates Tennessee sues Walgreens for opioid over-distribution FDA declines Nuplazid's indication for Alzheimer's psychosis Two BP readings better predicts ASCVD risk References: Statement by president Biden on Senate Passage of the inflation reduction act. The White House. https://bit.ly/3dcWRfs. Published August 7, 2022. Accessed August 11, 2022. Part D Senior Savings Model (insulin savings) common questions & answers. https://go.cms.gov/3SGrKcx. Accessed August 11, 2022. JYNNEOS vaccine. Centers for Disease Control and Prevention. https://bit.ly/3STVq6e. Published August 10, 2022. Accessed August 11, 2022. FDA authorizes intradermal use of Jynneos vaccine for Monkeypox. Medscape. https://wb.md/3C2K9ua. Published August 9, 2022. Accessed August 11, 2022. Assistant Secretary for Public Affairs (ASPA). Biden-Harris Administration Bolsters Monkeypox Response; HHS secretary Becerra declares public health emergency. HHS.gov. https://bit.ly/3pabFhK. Published August 5, 2022. Accessed August 11, 2022. Williams J. Judge says Walgreens contributed to San Francisco's opioid crisis. PBS. https://to.pbs.org/3zMFH04. Published August 10, 2022. Accessed August 11, 2022. Gorman S. Tennessee sues Walgreens Pharmacy chain over Opioid Distribution. Medscape. https://wb.md/3Qk2VkW. Published August 5, 2022. Accessed August 11, 2022. Staff R. FDA declines to approve expanded use of antipsychotic drug. Medscape. https://wb.md/3bIlSz2. Published August 5, 2022. Accessed August 11, 2022. Clark CE, Warren FC, Boddy K, et al. Higher arm versus lower arm systolic blood pressure and cardiovascular outcomes: A meta-analysis of individual participant data from the Interpress-IPD Collaboration. Hypertension. August 2022. doi:10.1161/hypertensionaha.121.18921. Whelton P, Carey R, Aronow W, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018 May, 71 (19) e127–e248. https://doi.org/10.1016/j.jacc.2017.11.006.

Roger Seheult, MD of MedCram examines how monkeypox spreads. See all Dr. Seheult's videos at: https://www.medcram.com (This video was recorded on August 11, 2022) Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine. MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS: MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested. MEDIA CONTACT: Media Contact: customers@medcram.com Media contact info: https://www.medcram.com/pages/media-contact Video Produced by Kyle Allred FOLLOW US ON SOCIAL MEDIA: https://www.facebook.com/MedCram https://twitter.com/MedCramVideos https://www.instagram.com/medcram DISCLAIMER: MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor. #COVID19 #Omicron #Coronavirus Kyle Allred, MedCram Co-Founder & Producer, Physician Assistant

New authorization for intradermal administration of monkeypox vaccine; a new approval for endometriosis pain; Amazon is among the companies to receive an FDA Warning Letter for selling unapproved drugs; a diabetes drug is found to contain a possible carcinogen; and a new scale that measures peripheral impedance and pulse rate.  

Imagine this: A wedding photographer booked a couple earlier this year. As the countdown grew closer to the big day, the monkeypox outbreak spread across the country, public health emergencies were declared, and the client spirals into a downright panic. The photographer opens up their email to find their client trying to get out of their contract due to the “national emergency”. Despite the photographers' best customer service skills, the couple keeps persisting and states that the situation is Force Majeure- they can't continue the event as planned and need to cancel ASAP. What should the photographer do? Do they have to cancel the event, refund the client, and take a huge loss? What legal leg do the clients actually have to stand on and ultimately…when IS a national public health emergency a valid cause for cancellation?    Recently, The Legal Paige Facebook Community has been getting TONS of questions regarding cancellations, public health emergencies, and monkeypox (cue horrific flashbacks to 2020). As an attorney, I can assure you that not every situation is a Force Majeure event (even if your client tries to say it is). This podcast episode will shed light on how to navigate public health emergencies, what constitutes a real Force Majeure event, and the tools you need to have in your legal toolkit to navigate situations like monkeypox moving forward (Covid-19 PTSD not included).    PUBLIC HEALTH EMERGENCIES + MONKEYPOX    A Public Health Emergency is declared by the Secretary of Health and Human Services when they have determined a disease that may be of public concern. Most Public Health Emergencies have an expiration of 90 days but can be extended if the Secretary feels appropriate. When a Public Health Emergency is declared it opens up more funding for vaccinations, a quicker response time, and additional resources (i.e. it fast tracks the issue).    On August 4th, U.S. Department of Health and Human Services Secretary Xavier Becerra declared Monkeypox a Public Health Emergency. Monkeypox is defined by the CDC as “a rare disease caused by infection with the monkeypox virus. Monkeypox virus is part of the same family of viruses as variola virus, the virus that causes smallpox. Monkeypox symptoms are similar to smallpox symptoms, but milder, and monkeypox is rarely fatal.”    If Monkeypox is a rare disease and is rarely fatal you are probably wondering why the White House decided to declare it a Public Health Emergency. In the last few weeks the US has seen a significant uptick in cases that has caused some concern. At the time of recording, there were 7,510 cases in the United States with numbers on the rise. There is a vaccination for Monkeypox called JYNNEOS, but there is a limited supply which is causing a shortage in hospitals and pharmacies.  By declaring Monkeypox a Public Health Emergency the Biden Administration put the disease in the #1 line for funding and it prioritized the production of the JYNNEOS vaccine.    WHAT ACTUALLY QUALIFIES AS A FORCE MAJEURE EVENT?    During the beginning stages of the Covid-10 pandemic, many clients were able to cancel their contracts for their events by enacting the Force Majeure Clause. They were able to do this because it was unforeseeable, unpredictable, and the contractual obligations were impossible to perform (those three things have to be true to be able to enact Force Majeure). With clients beginning to invoke Force Majeure again for the latest public health crisis, it's important to note that Monkeypox does not qualify as a Force Majeure event. In fact, MOST Public Health Emergencies don't. Force Majeure was created for out of the blue, “acts of god” like tornadoes,  hurricanes, wildfires, terrorism, war– events that no one could have imagined or anticipated. The beginning of Covid-19 qualified as Force Maejure because the world was unpredictably shut down. Nobody could leave their house. There was an inability for contracts to be executed. Even if your clients wanted to continue with their wedding in say April of 2020, they literally could not due to the shutdowns across the United States.    That ‘impossibility of performance' we saw with Covid-19  is what you need to keep in mind when new public health emergencies pop up. .Is it impossible for you to perform your contractual obligations because of the emergency? If so, you could probably enforce Force Majeure. If you CAN perform your obligations then you are just in general cancellation territory.    MORE FROM THIS EPISODE   Press play on Episode #136 to learn more about Force Majeure events, how to navigate public health emergencies with clients, the protection clauses you absolutely need to have in your contract, and more! If you haven't stocked your legal toolkit with a solid cancellation agreement, now is a great time to set yourself up for success.  The Legal Paige team and I are always watching things unfold in the news, so if monkeypox or any other public health emergencies take a wild turn for the worse…we will be updating you and helping you handle any sticky situations. Finally, remember our FREE Facebook Community is a great, go-to resource for industry professionals.

AMA Director of Science, Medicine and Public Health, Andrea Garcia JD, MPH, covers monkeypox cases, vaccines, Tecovirimat used for treatment, as well as two Biden administration reports and support services for Americans with long haul COVID. American Medical Association CXO Todd Unger hosts. Visit https://www.covid.gov/longcovid for federal services and supports for people experiencing longer term impacts of COVID-19. Access guidance and descriptors for new monkeypox CPT codes here: https://www.ama-assn.org/practice-management/cpt/orthopoxvirus-and-monkeypox-coding-guidance

This week on Pharm5: Pfizer's Phase 2 trials for revamped COVID vaccine Monkeypox updates: vaccines and treatment options Treating animal infections with OTC topical medications Uninsured rates hit historic US low ASHP's guidance to prevent controlled substance diversion References: Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate based on enhanced spike protein design. Pfizer. https://bit.ly/3OVxagF. Published July 27, 2022. Accessed August 4, 2022. FDA Briefing Document Vaccines and Related Biological Products Advisory Committee Meeting. https://bit.ly/3I1wZhY. Published June 28, 2022. Accessed June 30, 2022. JYNNEOS monkeypox vaccine distribution by jurisdiction. https://bit.ly/3vBs0zt. Accessed August 4, 2022. FDA provides update on agency response to Monkeypox Outbreak. U.S. Food and Drug Administration. https://bit.ly/3bw93rj. Published July 29, 2022. Accessed August 4, 2022. Lundberg A, Koch SN, Bierbrier L, Slater M. Treating common skin conditions of cats and dogs in a community setting. Today's Veterinary Practice. 2022:100-106. Accessed August 4, 2022. Spitnagel MB, Hillier A, Gober M, Carlson MD. Treatment complexity and caregiver burden are linked in owners of dogs with allergic/atopic dermatitis. Vet Dematol. 2021;32(2):192-e50. Accessed August 4, 2022. Assistant Secretary for Public Affairs (ASPA). New HHS report shows national uninsured rate reached all-time low in 2022. HHS.gov. https://bit.ly/3zwU48y Published August 2, 2022. Accessed August 4, 2022. Number of retail prescription drugs filled at pharmacies by payer. KFF. https://bit.ly/3QmntJ8 Published March 5, 2020. Accessed August 4, 2022. ASHP releases revised guidelines on preventing diversion of controlled substances. ASHP. https://bit.ly/3d5XZ4F. Published August 2, 2022. Accessed August 4, 2022.

  Vidcast:  https://youtu.be/utqGh5aJvwg   Monkeypox, the orthopox viral infection typically only occurring in Africa, is rapidly spreading around the world.   As of August 4th, the total number of worldwide cases was 26,864 with all but 345 occurring in countries where this disease has not been previously reported.   Though not usually fatal, at least 77 Africans have died and an additional 5 deaths have been reported outside of Africa.   The total number of confirmed US monkeypox cases as of August 4th is 7102 with cases occurring in every state except Montana and Wyoming.  Most current US cases associated with male-male sexual intimacy.  The states hit the hardest are New York, Florida, Illinois, Texas, and California.   The last major  US outbreak occurred in 2003 with 47 confirmed or probable cases in 6 states, Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, traced to infected pet prairie dogs that had been housed near imported small mammals from Africa.  Then, in 2021, two isolated cases of monkeypox were diagnosed in Maryland and in Texas when US residents contracted the disease on trips to Africa.    Current efforts to stop the monkeypox epidemic include vaccination and use of anti-viral agents.  A vaccination drive using the Danish monkeypox vaccine Jynneos or the older vaccinia viral vaccine ACAM2000 is underway but hampered by a vaccine shortage.  The available supply is being optimized by only administering the first of 2 recommended doses, and virologists estimate that even this one dose offers 2 years of protection.      The best defense is avoidance of person-to-person contact with a monkeypox-infected person or their personal articles as the virus can live for weeks on objects.  Those who have a social or occupational exposure to monkeypox including medical teams and diagnostic lab personnel should receive monkeypox pre-exposure prophylaxis or PrEP and that is vaccination.  How do you know you have monkeypox?  Non-specific signs of illness such as fever and chills, headache, muscle aches, fatigue are accompanied by or followed by the appearance of a rash that can be all over your body or more likely limited to points of contact where you contracted the disease.   The antiviral agent tecovirimat, TPOXX for short, is effective against monkeypox and prescribed for the most severe cases or in those with complicating medical problems.   https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html https://allafrica.com/view/group/main/main/id/00082929.html   #monkeypox #Jynneos #acam2000 #vaccination #tpoxx #tecovirimat  

Major announcement on today's show!We are returning this podcast back to its originally intended format: covering what's going on nationally and around the world. It was never my intention to cover local Austin news on this show. It just sort of happened with the Urban Alchemy story. Next thing you know, I have 4 straight shows about Austin. I've gotten a ton of feedback over the past few days from friends who don't live in Texas. They love the show and enjoy hearing my takes on what's going on - but they only have a “mild interest” in Austin news and politics. I totally understand. They say the definition of insanity is doing the same thing over and over again, and expecting a different result.I feel like continuing to cover Austin news and politics in this Democrat-dominated city would be an exercise in futility and a waste of my precious remaining time on Earth. After putting in hundreds of hours of research, writing, recording and making videos and doing podcasts about Austin over the past two years, why should I keep going when (a) it's not making any discernible difference and (b) I could be focusing my energy on other issues that will make an impact?Do you know what Teddy Brosevelt's total earnings have been over the past two years of covering Austin politics? $0 (minus web hosting and domains).So around negative -$200 for hundreds of hours of work. I certainly didn't start covering Austin politics for the income opportunities. It felt like my civic and patriotic duty to speak out against things that I knew in my heart and soul were WRONG.When I first started back in 2020, I was really passionate about fighting for freedom and trying to make Austin a better place to live. I'm still extremely passionate about fighting for freedom, truth and justice.But I'm 100% burnt out on Austin-related issues. If anyone wants the website AustinTexasTimes.com, I would be happy to give it to someone who cares and will do something with it. You can have everything - the content, theme, design, etc. It's a WordPress site, so it's easy to post content. I'm just done with Austin news. The thought of continuing to cover the corrupt, incompetent crooks who run this clown town makes me nauseous.Especially after they went ahead and hired Urban Alchemy last week, after all the dirt we dug up on them. Starting now, we are going back to the original focus on national and international news. EPISODE #24 TOPICS: Judge Maya Guerra Gamble is presiding over the Alex Jones trial in Travis County, Texas. Does she seem like a fair and impartial judge to you, based on this montage of photos from her Twitter? More on the Alex Jones show trial: Did the paralegal for Alex Jones' lawyer F. Andino Reynal intentionally leak two years of text messages? Did you know that Alex Jones' lawyer F. Andino Reynal was appointed by Eric Holder to be Assistant United States Attorney in the U.S. Southern District of Texas in 2009? Do you think Obama and Holder fully vetted Reynal's background before he was officially appointed?If so, do you think they would appoint a liberal Democrat to that position or a conservative? Who is ultimately F. Andino Reynal's bigger allegiance to: Barack Obama or Alex Jones? Thanks for reading Teddy Brosevelt! Subscribe for free to receive new posts, podcasts and videos. More topics: Karl Denninger discovered that the Monkeypox vaccine made by Jynneos has some seriously concerning side effects. How about this: 1.3% of Monkeypox vaccine recipients were reported to have “cardiac adverse events of special interest”. That's 95 out of 7,093 vaccine recipients having a cardiac issue. No one in the USA has died from Monkeypox. But you have 1.3% chance of permanently damaging your heart with the vaccine. Sound familiar? Nancy Pelosi provoked both North Korea and China in one trip. Great job!BOEM lies to the Louisiana shrimp industry about these totally worthless giant ocean fans. Don't worry, they are just going to dig a six foot deep trench on the ocean floor to run all the HVAC cables. The shrimp won't mind it one bit. Dick Cheney endorses Liz Cheney. Somehow Liz thinks this will get people in Wyoming to vote for her on August 13th. Wish we could legally bet on political outcomes in the USA. Might need to fly to London and make some bank.I need to escape Austin for a few days, clear my head and think about what I want to do next. But the place I'm going this weekend in the Ozark Mountains of Arkansas has shoddy internet, so this might be the last post and podcast for a couple days.Just need to emphasize and underscore: I'm absolutely going to keep writing on this Substack, recording the podcast and making videos. I'm more determined than ever to fight for truth, freedom and the American way.But I need to follow my heart and passion, and my passion for fighting for a better Austin has evaporated. This city is now the San Francisco of Texas. If that's what the people who live here want, let ‘em have it.Just look at Portland or Seattle. People stayed silent and ignored the major issues until it directly impacted them. By the time they finally got the courage to speak up, their city is a total disaster and it will take years (if not decades) to fix. That's going to be Austin this decade. Guaranteed. P.S. We will be creating fresh new intro and outro beats for the podcast this weekend. Next episode is a milestone (#25), so we've gotta cook up some special beats for that show Stream ‘The Teddy Brosevelt Show':SpotifyiHeartRadioApple PodcastsTuneIn RadioSubstackThank you for reading Teddy Brosevelt. This post is public so feel free to share it. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit teddybrosevelt.substack.com

New Zealand and Australia are neck-in-neck on the COVID deathalizer, but Australia is surging ahead on Monkeypox cases as it becomes the world's latest pestering pestilence. While the politicians continue with their virtue theatre and persecution of their enemies they are forcing ordinary people closer to famine and war. Join Tim Wilms and Dieuwe de Boer on Trad Tasman Talk. Both Australia and NZ are past the peak of the Omicron BA5 wave with NZ's mask mandates including punishing school children for not wearing masks making no difference to its case and death rate compared to Australia. ATAGI has approved the Moderna vaccine for children 6 months to 5 years who are immunocompromised, disabled or have complex health needs. Teal Independent for Kooyong Dr Monique Ryan berated Coalition MPs to put their masks on in Parliament even though she and her supporters have been maskless indoors countless times. The Monkeypox outbreak was the focus of this week's Australian National Cabinet Meeting. With 58 cases in Australia (3 in NZ) exclusively among men who have sex with men Chief Medical Officer Paul Kelly last week declared Monkepox a Communicable Disease of National Significance. Health Minister Mark Butler announced the Federal Government had secured 450,000 doses of the third-generation monkeypox vaccine Jynneos by Bavarian Nordic to be delivered this year and next for 'at risk' populations. The Victorian Government was busy in court this week prosecuting its political enemies. Neil Erikson's appeal against his 10-week prison sentence for disturbing a gay church service in May 2019 was heard in the County Court. Chief Judge Peter Kidd will deliver his judgment on August 29. National socialist Jimeone Roberts was sentenced to 150 hours of community service after being convicted of public nuisance for posting swastika stickers in Caulfield a Jewish area in Melbourne. Jacinda Ardern's response to inflation is to pump the economy with a cost of living relief payment which has even been sent to dead people. The Labour Party asked its supporters to donate part of their cost of living payment back to the party. Despite rising cash rates some banks in NZ are dropping their interest rates and increasing unemployment is viewed as the best way to crush inflation. The RBA raised interest rates by 50 bases points to 1.85% and the Albanese plans to end the fuel excise discount next month. The first parliamentary sitting fortnight of the new Australian Parliament saw Labor's promised 43% emissions reduction target by 2030 legislation pass the lower house. The Territory Rights legislation which would allow the ACT and the NT to legalize euthanasia also passed the lower house after a conscience vote. Despite only being on the job for less than three months Anthony Albanese is already on long service leave until September. In other Australian political news, Federal Court Justice Michael Lee ruled that both Mark McGowan and Clive Palmer defamed each other in 2020 awarding each $20k and $5k damages respectively while saying they wasted the court's time. The WA taxpayer was forced to fund McGowan's legal fees. NSW Deputy Liberal Leader Stuart Ayers has resigned after he admitted he tipped former Deputy Premier John Barilaro off about the New York Trade Commissioner position he was seeking. Victorian Liberal Opposition Leader Matthew Guy's Chief of Staff Mitch Catlin resigned over revelations he attempted to solicit 100k from a Liberal donor in fees for his private marketing company. The Unshackled Links:Website: https://www.theunshackled.netFacebook: https://www.facebook.com/TUnshackledTwitter: https://twitter.com/Un_shackledGab: https://gab.com/theunshackledMinds: https://www.minds.com/The_Unshackled/Telegram: https://t.me/theunshackledMeWe: https://mewe.com/p/theunshackledBitchute: https://www.bitchute.com/channel/theunshackled/Free eBook: http://theunshackledbattlefield.net/ Support Our Work: Membership: http://www.theunshackled.net/membershipDonate: https://www.theunshackled.net/donate/Paypal: https://www.paypal.me/TheUnshackledStore: https://www.theunshackled.net/store/See omnystudio.com/listener for privacy information.

The new Australian Parliament sat this week with MPs resuming their political theatre show and inflated sense of importance. Outside of the political bubble inflation surges again as do rainbows and monkeypox. Join Tim Wilms and Stephen Berry tonight to review the past fortnight live at 6pm Melbourne time and 8pm Auckland time on Trad Tasman Talk. Both Australia and NZ are at the peak of their Omicron BA5 wave. NZ is now reclassifying covid deaths as those dying exclusively from covid which has seen the official death tally drop by a third. ABS data released today stated that of all covid-related deaths in Australia 86% of them covid was the main contributing factor over other comorbidities. Australia's CMO Paul Kelly has declared monkeypox a communicable disease incident of national significance. ATAGI has recommended those currently most at risk, 98% of cases in the western outbreak are men who have sex with men, are given access to the 3rd generation sterilizing smallpox vaccine JYNNEOS. In the new Australian Federal Parliament Labor, the Greens, and the Teals were wearing masks but Coalition MPs were largely unmasked. Pauline Hanson walked out when new Senate President Sue Lines opened proceedings with the indigenous welcome to the country, this was to also protest Lines' plans to fly the indigenous flag permanently in the Senate. The new Father of the House Bob Katter also took aim at Lines' other idea to ditch the Lord's prayer at the beginning of Senate proceedings. NRL Team the Manly Warringah Sea Eagles lost against the Sydney Roosters 10-20 and likely won't make the finals after they did not allow seven Pacific Islander players to take part because they refused to wear rainbow pride jerseys. In Melbourne, the Shrine of Remembrance will be lit up in Rainbow lights on Sunday to recognize LGBTQ defense force members. The Tenants Action Wellington is protesting outside property management company Quinovic's Kent Tce office on Thursday with a list of 10 absurd demands. These include landlords providing evidence they are addressing repairs one week after being notified by tenants, all rents being permanently lowered to 25 percent of the lowest benefit, a minimum tenancy of five years with tenants able to exit earlier, abolishing flat inspections, one year notice before selling or reoccupying the house, a ban on evictions during winter months and emergencies and pets being allowed in all flats.   Austalia's inflation rate was 6.1% in the past year, fruit and vegetables prices rose by 7.3%, inflation grew by 1.8% in the last quarter. Treasurer Jim Chalmers stated inflation is projected to peak in December at 7.75%. The RBA meets next Tuesday with interest rates to rise by between 50 and 75 bases points. The Biden Administration is trying to redefine recession after the second quarter of negative growth for the US. The NZ Government is spending $14 million on ensuring 160,000 New Zealanders eligible for a cost of living payment have their bank account details up to date. In the aftermath of their police state lockdown enforcement Victoria Police has had to apologize to Avi Yemini for false arrest and detainments, they have dropped incitement charges against Monica Smit, Solihin Millin, and Jamal Aabazi. They have paid compensation paid to Age photographer Luis Ascui for pepper spraying him when he was covering an anti-lockdown protest. The NSW Government has forced children to work off lockdown fines which were disproportionately given to children from disadvantaged areas.  The Unshackled Links:Website: https://www.theunshackled.netFacebook: https://www.facebook.com/TUnshackledTwitter: https://twitter.com/Un_shackledGab: https://gab.com/theunshackledMinds: https://www.minds.com/The_Unshackled/Telegram: https://t.me/theunshackledMeWe: https://mewe.com/p/theunshackledBitchute: https://www.bitchute.com/channel/theunshackled/Free eBook: http://theunshackledbattlefield.net/ Support Our Work: Membership: http://www.theunshackled.net/membershipDonate: https://www.theunshackled.net/donate/Paypal: https://www.paypal.me/TheUnshackledStore: https://www.theunshackled.net/store/See omnystudio.com/listener for privacy information.

The monkeypox vaccine will soon be available in limited quantities to metro Atlanta residents. Georgia has received roughly 3,000 doses of the JYNNEOS vaccine, a two-dose vaccine series with 28 days between each dose, meaning there are enough vaccines in Georgia for about 1,500 people, according to a Friday press release from the Georgia Department of Public Health. #CobbCounty #Georgia #LocalNews      -            -            -            -            -            The Marietta Daily Journal Podcast is local news for Marietta, Kennesaw, Smyrna, and all of Cobb County.  Subscribe today, so you don't miss an episode! MDJOnline Register Here for your essential digital news.  Email bgdoughnut22@gmailcom for your chance to win a $15 gift card from Dough in the Box https://www.chattahoocheetech.edu/ https://cuofga.org/ https://www.esogrepair.com/ https://www.drakerealty.com/ https://doughinthebox.com/ https://cchl.com/ Find additional episodes of the MDJ Podcast here.  This Podcast was produced and published for the Marietta Daily Journal and MDJ Online by BG Ad Group For more information be sure to visit https://www.bgpodcastnetwork.com See omnystudio.com/listener for privacy information.

Stunning JWST Images Show New Details Of The Universe After many delays, a Christmas launch, and a months-long period of travel and testing, the first science images from the James Webb Space Telescope (JWST) were unveiled this week. The JWST has a huge multi-segmented mirror that allows it to gather faint light—and it sees in the infrared, allowing it to see through dust and gas and reveal details about the universe that were previously unseeable. On Monday, a short ceremony at the White House unveiled the first image, a “deep field” image taken by staring for hours at a piece of sky the size of a grain of sand held at arm's length. The image shows thousands of galaxies, including ones so distant that their images have been warped by the gravitational lensing effect of massive objects in between. On Tuesday, four more images were unveiled, including a spectrograph describing the atmosphere of a distant exoplanet, a cluster of galaxies known as Stephan's Quintet, the dying stars of the Southern Ring Nebula, and the star formation region known as the Carina Nebula. Amber Straughn, an astrophysicist and deputy project scientist for James Webb Space Telescope Science Communications joins Ira to talk about the images, and what lies ahead now that the JWST has entered its operational phase. To compare the JWST images side-by-side with the Hubble images of the same subjects, visit www.sciencefriday.com.   A Busy Time For Space Launches While much of the astronomical world was gazing at the first science images from the James Webb Space Telescope, there's been a lot of other space news to discuss—from launches and testing associated with the Artemis I mission to the moon to new data from the Martian rovers. There's also big news with commercial space flights, and even plans from some commercial vendors to work on a replacement for the aging International Space Station. Ira talks with Brendan Byrne, space reporter from WMFE and host of podcast “Are We There Yet?”, along with planetary scientist Matthew Siegler, about recent solar system news, and space events to keep an eye on in the months ahead.   U.S. Attempts To Catch Up With Rising Monkeypox Cases The outbreak of the orthopox virus currently known as monkeypox continues to spread in hotspots around the United States, with symptoms ranging from fever to intensely painful, contagious lesions. From five cases in late May, the known number has grown to at least 1,053 as of Wednesday afternoon, with epicenters including New York City, the Bay Area, Chicago, Washington D.C., and other major cities. But the current numbers most certainly are an undercount, as people seeking diagnosis report difficulty accessing tests. Meanwhile, the rollout of the existing monkeypox vaccine, Jynneos, remains slow and inadequate for demand, with more than a million doses still stuck in a stockpile in Denmark. So far, the virus, which is known to spread through respiratory droplets and skin-to-skin contact, has been detected predominantly in men who have sex with men. New York public health researcher Keletso Makofane and San Francisco AIDS Foundation CEO Tyler TerMeer speak to the frustration of LGBTQ men and nonbinary people in the most at-risk networks, as resources and response lag. And Ira talks to UCLA monkeypox researcher Anne Rimoin, who twelve years ago published a warning that cases were rising in African countries as immunity to the related smallpox virus waned. He also speaks with Brown University epidemiologist Jennifer Nuzzo about the outlook for global and domestic containment, and the pressing need for more data.   Transcripts for each segment will be available the week after the show airs on sciencefriday.com.          

  Vidcast:  https://youtu.be/GrJf8ShaRRc   Monkeypox, the orthodox virus that is a cousin of smallpox, is rapidly spreading around the world and…. within the US.  The CDC has confirmed over 300 cases in at least 28 states with the population-dense states of California, New York, Florida, and Illinois heading the pack.  So far, most of the US cases have involved sexual transmission, but, as the amount of monkeypox virus circulating rises, the virus could spread by more casual contact or through the air on respiratory droplets.   The CDC and the Biden administration are ramping up supplies of the preferred vaccine against monkeypox, Jynneos, but the demand far outpaces the available suppl.  That being the case, your best bet is avoiding a monkeypox infection.   If you received a smallpox vaccination years ago, you may have some residual protection.  Don't count on it though.  Monkeypox is spread by contact with the characteristic skin lesions, by bodily secretions from an infected person, and by aerosol droplets from such a person.   Avoid prolonged contact with the skin of a person who may be infected or who has a rash with characteristic monkeypox macules, papules, or pustules.   Don't be having intimate contact with people you don't know well.  To avoid an infectious cloud of monkeypox in a crowd, use your dependable N95 mask.   If you think you have monkeypox, immediately consult your personal medical team or a hospital team.  Testing is available as is treatment with the antiviral agents TPOXX, cidofovir, and Vaccinia Immune Globulin IV.  These agents are not proven to be effective for monkeypox, so avoiding it is the best strategy.   What about vaccination?  Healthcare personnel and first responders with a monkeypox exposure risk should be vaccinated.  If you have been exposed to a person with known or suspected monkeypox, speak with your medical team or local public health department about vaccination.   One more thing:  monkeypox, like CoVid, has been shown to be mutating.  The best way we can all protect ourselves from yet another devastating pandemic is to avoid being infected.  Mutations occur when the virus replicates within a human host.   https://www.cdc.gov/poxvirus/monkeypox/clinicians/treatment.html   https://www.cdc.gov/poxvirus/monkeypox/clinicians/treatment.html   #monkeypox #vaccine #STD #aerosol #Jynneos #TPOXX   

Vidcast:  https://youtu.be/VQj4zPuGqdY   We've talked about a twindemic this spring of both CoVid and Influenza, but now we have monkeypox threatening to make it a tridemic.  So what should you know about monkeypox?   Monkeypox is an orthopoxvirus, a cousin of the smallpox virus, that was first identified in 1958 in a colony of African monkeys.  The first human case was noted in 1970, again in Africa, and the majority of infections occur in the Democratic Republic of the Congo.  The virus is mostly carried by rodents such as mice, rats, and squirrels.   Monkeypox does not occur naturally in the US, and all cases here stem from International travelers bringing in the virus.  As of June 1st, monkeypox cases have been identified in 10 states and in more than 23 countries.   Monkeypox begins with typical symptoms of viral infections including fever, headache, muscle aches, and fatigue after a 5 to 21 day incubation period.  One to three days after symptom onset, a rash appears followed by discrete lesions that become bumpy, liquid-filled, and pus-filled, that break giving way to scabs after a total of 2 to 4 weeks.     The disease is spread by infected secretions during close and intimate contact including sex but may also be spread through respiratory secretions.  Spread is prevented by avoiding contact with sick animals and people, careful hand washing and use of alcohol hand sanitizers, and masking as well as use of eye protection around those who are infected.  The very young, elders, pregnant women, and those with immune deficiencies are at particular risk.   Those previously immunized against smallpox should have some protection, but it likely has waned over time.  Most at risk currently are younger persons who never received the smallpox vaccine.  At this time, vaccination is not being recommended but that may change if the disease is spreading.  If it is, problems will arise as available vaccines to monkeypox, JYNNEOS and the older ACAM200, are in short supply.   There are several anti-viral medications, tecovirimat and brincidofovir, that counteract monkeypox, but their effectiveness in treating human monkeypox has not been proven.  Vaccinia immune globulin is available and may provide effective treatment for those infected.  To prevent spread, any infected person should quarantine for 21 days.   https://www.cdc.gov/poxvirus/monkeypox/treatment.html   #Monkeypox #smallpox #vaccinia #tecovirimat #brincidofovir  

This week on Pharm5: Monkeypox vaccine for work-related exposure to orthopoxvirus Lymphoma drug Ukoniq (umbralisib) loses FDA approval Psychedelic, synthetic psylocibin tested for use in severe depression Expanding uses for antineoplastic agent azacitidine Addendum to the 2022 Standards of Medical Care in Diabetes References: Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. Centers for Disease Control and Prevention. https://bit.ly/3MkpYtq. Published May 27, 2022. Accessed June 2, 2022. FDA withdraws lymphoma drug approval after investigation. Medscape. https://wb.md/3GJIMRw. Published June 1, 2022. Accessed June 2, 2022. Melville NA. Psilocybin effective up to 12 weeks in severe depression. Medscape. https://wb.md/3xeigg5. Published June 2, 2022. Accessed June 2, 2022. DRUGS@FDA: FDA-approved drugs. accessdata.fda.gov. https://bit.ly/3Mr6kvT. Accessed June 2, 2022. Center for Drug Evaluation and Research. FDA approves azacitidine. U.S. Food and Drug Administration. https://bit.ly/3xdSoRw. Published May 20, 2022. Accessed June 2, 2022. FDA approves Ivosidenib/Azacitidine for certain patients with newly diagnosed AML. The ASCO Post. https://bit.ly/3GHaoGY. Published May 26, 2022. Accessed June 2, 2022. Addendum. 10. cardiovascular disease and risk management: Standards of medical care in diabetes–2022. diabetes care 2022;45(suppl. 1):S144–S174. Diabetes Care. May 2022. doi:10.2337/dc22-ad08 Aspirin use to prevent cardiovascular disease: Preventive medication. Recommendation: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce. https://bit.ly/3m93gtn. Published April 26, 2022. Accessed Jun 2, 2022.

In a hyperbolic over-reaction, the US government announced the purchase of 13 million doses of the clinically unproven Jynneos vaccine. Some vaccine enthusiasts have proposed perimeter or rim vaccination of monkeypox contacts. This appears unjustified since the virus spreads by intensive physical contact (kissing, sex, touching blisters/pustules) and is not...

In a hyperbolic over-reaction, the US government announced the purchase of 13 million doses of the clinically unproven Jynneos vaccine. Some vaccine enthusiasts have proposed perimeter or rim vaccination of monkeypox contacts. This appears unjustified since the virus spreads by intensive physical contact (kissing, sex, touching blisters/pustules) and is not...

This episode discusses four MMWR reports. The first report examines ACIP's recommendation for use of the JYNNEOS vaccine in people aged 18 years and older at risk for occupational exposure to orthopoxviruses such as monkeypox. The second report describes post-COVID conditions among adult COVID-19 survivors aged 18 years and older. The third report highlights barriers to and disparities in access to health care among adults aged 18 years and older with epilepsy. And the last report looks at seizure- or epilepsy-related emergency department visits before and during the COVID-19 pandemic.

This episode discusses four MMWR reports. The first report examines ACIP's recommendation for use of the JYNNEOS vaccine in people aged 18 years and older at risk for occupational exposure to orthopoxviruses such as monkeypox. The second report describes post-COVID conditions among adult COVID-19 survivors aged 18 years and older. The third report highlights barriers to and disparities in access to health care among adults aged 18 years and older with epilepsy. And the last report looks at seizure- or epilepsy-related emergency department visits before and during the COVID-19 pandemic.

When unnamed Bloomberg sources said that Dexcom is in talks to buy Insulet in what could be the year's biggest medtech megamerger, stock prices went wild. And the American Society for Clinical Oncology annual meeting, the biggest cancer conference, will be held in June, but we have early news to share. Also under discussion is the new monkeypox outbreak, what the treatment options are and why health officials don't seem concerned. Lastly, nominations are finally open for the annual Fierce 15 competition. We'll hear from the judges about what it takes to make your nomination stand out from the rest.    To learn more about the topics in this episode: Roche rolls out trio of PCR research tests for monkeypox Bavarian Nordic signs 'larger' monkeypox vaccine supply deal with unnamed country US to provide Bavarian Nordic's vaccine Jynneos to some at risk for monkeypox, CDC says Moderna tunes vaccine platform to next potential viral threat: monkeypox Monkeypox outbreak won't be the next global pandemic thanks to vaccines, drugs: analysts Dexcom, Insulet in talks to merge into a diabetes device behemoth: report Biohaven flunks first clinical test for rare disease drug post-Pfizer sell-off ASCO: Is another pan-tumor drug on the horizon? Johnson & Johnson thinks Balversa could be it ASCO: J&J, Legend reveal more CAR-T data and a look at Carvykti for earlier myeloma in a difficult population ASCO: J&J's multiple myeloma toolkit expands with bispecifics data ASCO: Novartis eyes full nod for Gleevec follow-on Scemblix thanks to new leukemia data GSK dodges UK strike with improved pay offer for staffers Calling all Fierce 15 fans: Nominations for the 2022 Fierce Biotech Fierce 15 are now open The Top Line is produced by senior multimedia producer Teresa Carey with editor-in-chief Tracy Staton, managing editor Querida Anderson and senior editors Annalee Armstrong, Ben Adams, Conor Hale and Eric Sagonowsky. The sound engineer is Caleb Hodgson. The stories are by all our “Fierce” journalists. See omnystudio.com/listener for privacy information.

The Us has ordered 13 million additional doses of the monkeypox vaccine after a Massachusetts man contracted the rare — but potentially severe — virus, officials said Thursday.  The massive $119 million order of Jynneos jabs — which can be used to treat both the monkeypox virus and smallpox — was created by the biotechnology company Bavarian Nordic, according to Newsweek. https://www.dailymail.co.uk/news/article-10839325/NYC-warns-residents-wear-mask-local-tests-positive-virus-related-monkeypox.html   Check me out on   This is a link to my fb group   https://www.facebook.com/groups/10902...   https://www.spreaker.com/episode/4972...   Twitter.com Hardtalkradio Live in 4k        Instagram Hardtalk79                https://cash.app/$HARDTRADIO Feel free to donate if you feel to do so and like the content.      If you have any current event stories or videos  that you want me to cover hit me up at Redpillman1988@gmail.com --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/red-pill-man/support

The Us has ordered 13 million additional doses of the monkeypox vaccine after a Massachusetts man contracted the rare — but potentially severe — virus, officials said Thursday.  The massive $119 million order of Jynneos jabs — which can be used to treat both the monkeypox virus and smallpox — was created by the biotechnology company Bavarian Nordic, according to Newsweek. https://www.dailymail.co.uk/news/article-10839325/NYC-warns-residents-wear-mask-local-tests-positive-virus-related-monkeypox.html  Check me out on  This is a link to my fb group Points of View https://www.facebook.com/groups/10902...  https://www.spreaker.com/episode/4972...   Twitter.com Hardtalkradio Live in 4k        Instagram Hardtalk79                https://cash.app/$HARDTRADIO Feel free to donate if you feel to do so and like the content.     If you have any current event stories or videos  that you want me to cover hit me up at Redpillman1988@gmail.com --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/red-pill-man/support

Here are the links for everything discussed in Episode 4 Approval of Rybelsus for treatment of type 2 diabetes Expanded indications for Pifeltro & Delstrigo Approval of Jynneos vaccine for monkeypox/smallpox Update on NDMA found in ranitidine products Flu Part 4 Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin Connect with Kathy Bender PharmD. on social media:Instagram      Linkedin        ★ Support this podcast on Patreon ★